{ Spot Image }
600 New Hampshire Avenue, N.W.
Washington, D.C. 20037
F: 202.536.2013

  • Law clerk to the Honorable Christopher F. Droney, United States Court of Appeals for the Second Circuit
  • Northwestern University School of Law, J.D., magna cum laude
  • Order of the Coif
  • Special Sections Editor, Northwestern University Law Review
  • New York University, B.A., magna cum laude
Bar and Court Admissions
  • District of Columbia
  • Illinois
  • United States Court of Appeals for the Seventh Circuit
  • United States District Court for the Northern District of Illinois

Emily Damrau

Photo of Emily  Damrau

Emily Damrau’s practice focuses on complex civil litigation, white collar matters, and appellate litigation.

Prior to joining MoloLamken, Emily Damrau served as a law clerk to the Honorable Judge Christopher F. Droney of the United States Court of Appeals for the Second Circuit. During law school, Ms. Damrau interned with the United States Attorney’s Office for the Northern District of Illinois.

Representative Matters

  • Impression Prods., Inc. v. Lexmark Int’l, Inc., 137 S. Ct. 1523 (2017) – Drafted amicus brief on behalf of leading cellular wireless technology company in case addressing patent exhaustion doctrine
  • 616 Croft Ave., LLC v. City of West Hollywood, 138 S. Ct. 377 (2017) – Drafted successful brief in opposition to a petition of certiorari regarding permit conditions subject to unconstitutional conditions doctrine
  • Cabinet member in connection with Inspector General investigation
  • Senior executive of Fortune 100 company in connection with DOJ criminal and civil false claims investigation
  • Chief Marketing Officer of telecommunications company in connection with DOJ investigation into alleged FCPA violations
  • Senior executives of pharmaceutical company in DOJ investigation involving off-label marketing allegations
  • Senior executive of drug manufacturer in DOJ and SEC investigations into alleged FCPA violations
  • Representation of global pharmaceutical company in $2.3 billion fraud and breach of contract suit
  • Representation of tribal nation in suit against opioid manufacturers